Immunotherapy-based novel nanoparticles in the treatment of gastrointestinal cancer: Trends and challenges

Gastrointestinal cancer (GIC) is the most common cancer with a poor prognosis. Currently, surgery is the main treatment for GIC. However, the high rate of postoperative recurrence leads to a low five-year survival rate. In recent years, immunotherapy has received much attention. As the only immunoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Yi-Nan, Xue, Ming, Tang, Qiu-Sha, Wang, Li-Jun, Ding, Hui-Yan, Li, Han, Gao, Cheng-Cheng, Yu, Wei-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611702/
https://www.ncbi.nlm.nih.gov/pubmed/36312831
http://dx.doi.org/10.3748/wjg.v28.i37.5403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611702/
https://www.ncbi.nlm.nih.gov/pubmed/36312831
http://dx.doi.org/10.3748/wjg.v28.i37.5403

Ejemplares similares